相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK/ERK pathway
Ya-Ling Qi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
TBX1 and Basal Cell Carcinoma: Expression and Interactions with Gli2 and Dvl2 Signaling
Cinzia Caprio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Silencing of Long Non-coding RNA RP1-93H18.6 Acts as a Tumor Suppressor in Cervical Cancer through the Blockade of the PI3K/Akt Axis
Qian Wang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer
Yuxuan Song et al.
Aging-US (2020)
TMBIM6/BI-1 contributes to cancer progression through assembly with mTORC2 and AKT activation
Hyun-Kyoung Kim et al.
NATURE COMMUNICATIONS (2020)
Immunotherapy With Radiotherapy and Chemoradiotherapy for Cervical Cancer
Christine H. Feng et al.
SEMINARS IN RADIATION ONCOLOGY (2020)
Cervical cancer prevention in China: a key to cancer control
Fanghui Zhao et al.
LANCET (2019)
Downregulation of microRNA-205 inhibits cell invasion and angiogenesis of cervical cancer through TSLC1-mediated Akt signaling pathway
Fang Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling
Yilin Che et al.
CANCER LETTERS (2019)
Pharmacodynamics of current and emerging treatments for cervical cancer
Alfonso Duenas-Gonzalez et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)
MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway
Yong-Jie Li et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways
Na Wang et al.
THYROID (2019)
PDK1: At the crossroad of cancer signaling pathways
Paolo Armando Gagliardi et al.
SEMINARS IN CANCER BIOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Heterozygous Mutations in TBX1 as a Cause of Isolated Hypoparathyroidism
Dong Li et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
MicroRNA-451a acts as tumor suppressor in cutaneous basal cell carcinoma
Hui Sun et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2018)
Expression, function, and regulation of the embryonic transcription factor TBX1 in parathyroid tumors
Chiara Verdelli et al.
LABORATORY INVESTIGATION (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin
Yeqian Feng et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2017)
MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7
Boya Deng et al.
TUMOR BIOLOGY (2015)
22q11.2 deletion syndrome
Donna M. McDonald-McGinn et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
The T-box gene family: emerging roles in development, stem cells and cancer
Virginia E. Papaioannou
DEVELOPMENT (2014)
Microdeletions/duplications involving TBX1 gene in fetuses with conotruncal heart defects which are negative for 22q11.2 deletion on fluorescence in-situ hybridization
M. Chen et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2014)
A Novel Role for the T-Box Transcription Factor Tbx1 as a Negative Regulator of Tumor Cell Growth in Mice
Carol S. Trempus et al.
MOLECULAR CARCINOGENESIS (2011)
Substantial Improvement in UK Cervical Cancer Survival with Chemoradiotherapy: Results of a Royal College of Radiologists' Audit
C. L. Vale et al.
CLINICAL ONCOLOGY (2010)
22q11 Deletion Syndrome: A Role for TBX1 in Pharyngeal and Cardiovascular Development
Peter J. Scambler
PEDIATRIC CARDIOLOGY (2010)
Inhibition of Akt signaling by SN-38 induces apoptosis in cervical cancer
Youqing Liu et al.
CANCER LETTERS (2009)
Oridonin induces apoptosis via PI3K/Akt pathway in cervical carcinoma HeLa cell line
Hong-zhen Hu et al.
ACTA PHARMACOLOGICA SINICA (2007)
分享论文
